Sign in to continue:

Wednesday, May 6th, 2026

OFS Capital Corporation Reports Q4 2025 Financial Results: Net Investment Income, Portfolio Yields, and Net Asset Value Highlights




OFS Capital Corporation Q4 2025 Results – In-Depth Analysis for Investors

OFS Capital Corporation Announces Q4 2025 Results: Key Highlights & Investor Takeaways

Summary of Financial Results for Q4 2025

  • Net Investment Income (NII): OFS Capital reported NII of \$0.20 per common share for the quarter ended December 31, 2025, compared to \$0.22 per share in Q3 2025. This marks a slight sequential decline, potentially signaling margin pressures or lower portfolio income.
  • Net Loss on Investments: The company posted a net loss on investments of \$1.01 per common share for the quarter, primarily due to net unrealized depreciation of \$0.96 per share. Portfolio markdowns, especially on non-accrual debt and structured finance securities, were key drivers.
  • Net Asset Value (NAV): NAV per common share fell to \$9.19 at December 31, 2025, down from \$10.17 at September 30, 2025 — a notable decrease that investors should monitor closely as it reflects portfolio value pressures.
  • Distribution: The Board declared a Q1 2026 distribution of \$0.17 per common share, payable March 31, 2026, to stockholders of record as of March 20, 2026. This is an important data point for income-focused investors and reflects management’s outlook on future cash flows.
  • Portfolio Yield: The investment portfolio’s weighted-average performing income yield increased to 13.5% in Q4 from 13.3% in Q3, primarily due to higher yields on structured finance securities. This is a positive for income generation.
  • Portfolio Activity: Total investments (at fair value) stood at \$342.0 million (104% of amortized cost as of December 31, 2025). Debt investments comprised \$179.8 million (95% first lien, 5% second lien), and equity investments were \$100.6 million.
  • Credit Facility Update: On January 9, 2026, OFS Capital amended its Banc of California Credit Facility, extending the maturity date from February 28, 2026 to February 28, 2028, thus enhancing liquidity visibility and financial flexibility.

Additional Details for Investors

  • Investment Activity: For Q4, the company made \$8.0 million in debt and equity investments and \$1.5 million in structured finance securities purchases. Total investment purchases and originations were \$9.5 million, down from \$18.1 million in the previous quarter, indicating a more selective or cautious investment stance.
  • Portfolio Health: One loan was placed on non-accrual status in Q4, while some previously non-accrual loans were restructured back to accrual status. As of December 31, 2025, the portfolio included \$13.2 million in unfunded commitments to portfolio companies.
  • Liquidity Position: Cash and cash equivalents amounted to \$3.4 million at quarter end, with an additional \$20.5 million in unused borrowing capacity under the Banc of California credit facility (subject to covenants).
  • Operating Results: Total investment income for Q4 was \$9.4 million, a decline of \$1.2 million from the prior quarter. The drop was attributed to lower non-recurring income, the impact of interest rate cuts, and a smaller performing interest-bearing portfolio.
  • Expense Management: Total expenses fell by \$0.9 million sequentially, mainly due to lower incentive fees and interest expense.
  • Portfolio Losses: The total net loss on investments was \$13.5 million, largely from net unrealized depreciation (\$8.3 million on non-accrual debt, \$3.4 million on Structured Finance Securities).

Price-Sensitive and Shareholder-Relevant Information

  • Significant Drop in NAV: The quarter’s NAV decline of nearly 10% is material and could impact investor sentiment and share price — especially given the continued net investment losses and portfolio markdowns.
  • Distribution Maintained: Despite the NAV drop and investment losses, the Board maintained the quarterly distribution, which could support the stock price in the near term due to income investor demand but raises questions about sustainability if losses persist.
  • Credit Facility Extension: The two-year extension of the Banc of California Credit Facility maturity is a positive for liquidity and reduces refinancing risk, which could underpin confidence in the company’s ability to support its portfolio and dividend.
  • Portfolio Performance and Non-Accruals: The increase in non-accruals and markdowns, particularly on specific debt and structured finance securities, is a risk factor that investors should monitor, as it can lead to further NAV erosion and possibly impact future distributions.
  • Conference Call Details: Management will host a call on March 3, 2026, at 10:00 AM ET to discuss results; this could provide further clarity on portfolio strategy, credit performance, and forward guidance.

Conclusion

OFS Capital’s Q4 2025 results highlight ongoing challenges with portfolio valuations and non-accruals, as reflected in the notable NAV drop and investment losses. The company’s ability to maintain its distribution, extend its credit facility maturity, and generate a higher portfolio yield are positives. However, the sequential declines in NII and total investment income, coupled with the risk of further credit losses, make this a critical period for investors to closely monitor management commentary and subsequent quarters’ performance. These developments are likely to be price sensitive and could drive share price volatility in the near term.

Disclaimer


The information provided above is based on OFS Capital Corporation’s Form 8-K and press release disclosures for the quarter ended December 31, 2025. This is not investment advice. Investors should conduct their own due diligence and consult professional advisors before making investment decisions. The company’s actual results may differ materially from those expressed or implied due to various risks and uncertainties.




View OFS Capital Corp Historical chart here



American Healthcare REIT Declares $0.25 Per Share Q1 2026 Dividend Payable April 17, 2026 1

American Healthcare REIT Declares Q1 2026 Distribution – Key...

   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today